Renovaro Biosciences Inc.

Ticker RENB

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

11-50 Employees
Based in Los Angeles, California

Renovaro Biosciences, Inc. is a biotechnology company committed to developing advanced allogenic cell and gene therapies to promote stronger immune system responses potentially for long-term or life-long cancer remission in some of the deadliest cancers, and potentially to treat or cure serious infectious diseases such as HIV and Hepatitis B virus (HBV) infection.

Visit website

REPORT RATINGS

4.8 / 5.0 (161)

Renovaro Biosciences Inc. reports have an aggregate usefulness score of 4.8 based on 161 reviews.

Renovaro Biosciences Inc.